| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1330 | 4-O-Pivaloyl-L-DOPA |
1330.0015: 15 mg per vial 1330.0030: 30 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Precursor for 6-[18F]Fluoro-L-DOPA
|
||
| Molar Mass: 281.3 | ||
| C14H19NO5 | ||
| [122551-95-5] | ||
| Colourless to nearly colourless solid packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: L-Tyrosine, 3-hydroxy-, 4-(2,2-dimethylpropanoate) |
||
|
Synonymes: 4-O-Pivaloyl-3-hydroxy-L-phenylalanine; L-3-(3-Hydroxy-4-pivaloyloxyphenyl)alanine; PDOPA; PivDOPA |
||
|
Literature: 1. Bodor N. et al. Improved Delivery through Biological Membranes. 4. Prodrugs of L-Dopa. J. Med. Chem. 1977, 20, 1435-1445. |
||
| 2. Ihara M. et al. New Potential Prodrug to Improve the Duration of L-Dopa: L-3-(3-Hydroxy-4-pivaloyloxyphenyl)alanine. J. Pharm. Sci. 1989, 78, 525-529. | ||
| 3. Ishiwata K. et al. Electrophilic Synthesis of 6-[18F]Fluoro-L-DOPA: Use of 4-O-Pivaloyl-L-DOPA as a Suitable Precursor for Routine Production. Appl. Radiat. Isot. 1993, 44, 755-759. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1